Announced details
Ophthalmology, myopia, age-related macular degeneration (AMD), choroid and blood vessels, ophthalmic research
The Company participated in the Annual Meeting, presented research results and exhibited a booth. In the past, through research presentations and booth exhibitions, the Company has held discussions with researchers and global companies and built a network toward licensing agreements.
An ophthalmological society with more than 11,000 members across 75 countries.
Denver, Colorado, United States (venue of the meeting)
It is stated that efforts were made to create business opportunities leading to future business development. The specific amount of the impact on financial results is Not disclosed.
The company does not address Contract Value / Offering price.
ARVO (The Association for Research in Vision and Ophthalmology) 2026 Annual Meeting
| Item | Details |
|---|---|
| Counterparty | ARVO（The Association for Research in Vision and Ophthalmology） |
| Counterparty overview | An ophthalmological society with more than 11,000 members across 75 countries. |
| Relationship with the Company | The Company participated in the Annual Meeting, presented research results and exhibited a booth. In the past, through research presentations and booth exhibitions, the Company has held discussions with researchers and global companies and built a network toward licensing agreements. |
| Launch date | 3 to 7 May 2026 (actual, local time) |
| Applicable area | Ophthalmology, myopia, age-related macular degeneration (AMD), choroid and blood vessels, ophthalmic research |
| Location | Denver, Colorado, United States (venue of the meeting) |
| Impact on Business Performance | It is stated that efforts were made to create business opportunities leading to future business development. The specific amount of the impact on financial results is Not disclosed. |
| Source | ARVO (The Association for Research in Vision and Ophthalmology) 2026 Annual Meeting |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the latest research results and create business opportunities leading to future business development through discussions with researchers and global companies.